您当前所在的位置:首页 > 产品中心 > 产品信息
Mercaptopurine_分子结构_CAS_50-44-2)
点击图片或这里关闭

Mercaptopurine

产品号 DB01033 公司名称 DrugBank
CAS号 50-44-2 公司网站 http://www.ualberta.ca/
分子式 C5H4N4S 电 话 (780) 492-3111
分子量 152.17706 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 905

产品价格信息

请登录

产品别名

标题
Mercaptopurine
IUPAC标准名
6,7-dihydro-3H-purine-6-thione
IUPAC传统名
6-mercaptopurine
商标名
Purinethol
Mern
Leukerin
Ismipur
Leupurin
Mercaleukim
Mercaleukin
Puri-Nethol
Purimethol
别名
Mercapurin
Mercaptopurine Monohydrate
6 MP
MP
6-Mercaptopurine

产品登记号

CAS号 50-44-2
PubChem SID 46506988
PubChem CID 667490

产品性质

疏水性(logP) -0.4
溶解度 6.85 mg/mL

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. [PubChem]
Indication For remission induction and maintenance therapy of acute lymphatic leukemia.
Pharmacology Mercaptopurine is one of a large series of purine analogues which interfere with nucleic acid biosynthesis and has been found active against human leukemias. It is an analogue of the purine bases adenine and hypoxanthine. It is not known exactly which of any one or more of the biochemical effects of mercaptopurine and its metabolites are directly or predominantly responsible for cell death.
Toxicity Signs and symptoms of overdosage may be immediate such as anorexia, nausea, vomiting, and diarrhea; or delayed such as myelosuppression, liver dysfunction, and gastroenteritis. The oral LD50 of mercaptopurine was determined to be 480 mg/kg in the mouse and 425 mg/kg in the rat.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic. Degradation primarily by xanthine oxidase. The catabolism of mercaptopurine and its metabolites is complex. In humans, after oral administration of 35S-6-mercaptopurine, urine contains intact mercaptopurine, thiouric acid (formed by direct oxidation by xanthine oxidase, probably via 6-mercapto-8-hydroxypurine), and a number of 6-methylated thiopurines. The methylthiopurines yield appreciable amounts of inorganic sulfate.
Absorption Clinical studies have shown that the absorption of an oral dose of mercaptopurine in humans is incomplete and variable, averaging approximately 50% of the administered dose. The factors influencing absorption are unknown.
Half Life Triphasic: 45 minutes, 2.5 hours, and 10 hours.
Protein Binding Plasma protein binding averages 19% over the concentration range 10 to 50 µg/mL (a concentration only achieved by intravenous administration of mercaptopurine at doses exceeding 5 to 10 mg/kg).
External Links
Wikipedia
RxList
Drugs.com

参考文献